DDCRS 2025

COLORECTAL CANCER, PELVIC FLOOR AND FUNCTIONAL DISORDERS

9-10th January 2025

Bush House, King’s College London

​

Programme

​

Thursday 9th January 2025 - Pelvic Floor & Functional Disorders

​​

Co-Programme Convenor: Emma Carrington, St Mary's Hospital, London & Marc Gladman, King's College Hospital, London

​

08:30 - 09:00 Welcome

 

08:30 - 08:40 Pelvic Floor Conditions: 'The Big Picture' - Joseph Nunoo-Mensah, King's College Hospital & Cleveland Clinic London, London, UK 

 

08:40 - 09:10 DEBATE Session I:

​

This house believes that the anal sphincter is the most important organ for continence. I differ. – It's the rectum? Andrew Williams, London Bridge Hospital, London, UK vrs Emma Carrington, St Mary's Hospital, London.

​

Moderators: Joseph Nunoo-Mensah, King's College Hospital & Cleveland Clinic London, London, UK & Piero Nastro, Dartford and Gravesham NHS Trust, Dartford, UK

​

09:10 - 10:30 Advancing Theories, Diagnostics & Standardization in Pelvic Floor Dysfunction

​

Moderators: Andrew Williams, London Bridge Hospital, London & Liliana Bordeianou, Mass General Brigham HealthCare Colorectal Surgery Collaborative, Boston, USA

​

• The Integral Theory of pelvic floor dysfunction - Darren Gold, St Vincent's Hospital, Sydney, Australia

• Anorectal manometry. Which patients and what technique - Linda Ferrari, Guy's & St Thomas' NHS Foundation, London, UK

• Transperineal ultrasound. Is this the future? - Giulio Santoro Treviso Regional Hospital, Treviso, Italy.

• Why we need a standardized approach. The London protocol and classification - Emma Carrington, St Mary's Hospital, London, UK

• Discussion

 

10:30 - 11:00 DEBATE SESSION II:

​

MRI defecography vrs X‐ray video defecography in assessing ODS/prolapse. My way is the best! Tina Mistry, Guy's & St Thomas' NHS Foundation, London, UK (For MRI) vrs Michael North, Oxford University Hospital NHS Foundation Trust, Oxford, UK (For X-Ray)

​​

Moderators: Giulio Santoro Treviso Regional Hospital, Treviso, Italy & Marc Gladman, King's College Hospital, London, UK 

​

11:00 - 11:30 Coffee Break

 

11:30 - 12:50 Rethinking treatment for faecal incontinence

​

Moderators: Emma Carrington, St Mary's Hospital, London, UK & Linda Ferrari, Guy's & St Thomas' NHS Foundation, London, UK

 

• Anal sphincteroplasty - The Good, The Bad & The Ugly - Philip Bearn, Ashford and St Peter's Hospitals, Chertsey, UK

• Faecal incontinence a standard algorithmic approach - Liliana Bordeianou, Mass General Brigham HealthCare Colorectal Surgery Collaborative, Boston, USA

• Optimising and refining operative techniques for Sacral Nerve Stimulation (SNS) for Faecal Incontinence - Marc Gladman, King's College Hospital, London, UK

• Gatekeeper, Sphinkeeper & injectables - Minimally invasive surgical treatment of faecal incontinence. Where do they fit? - Andrew Clarke, Poole Hospital, Poole, UK

• Discussion

 

12:50 - 13:20 DEBATE SESSION III:

​

Pelvic Organ Prolapse Suspension (POPS) vrs ventral rectopexy for Obstructed Defecation Syndrome (ODS). JJoaquim Costa-Pereira, Hospital de Braga, Braga, Portugal (For POPS) vrs Andrew Clarke, Poole Hospital, Poole, UK (For VR)

 

Moderators: Darren Gold, St Vincent's Hospital, Sydney, Australia & Marc Gladman, King's College Hospital, London, UK

​

13:20 - 13:55 Sponsors Session

​

Moderators: Dimitrios Pissas, York and Scarborough NHS Foundation Trust, York, UK & Joseph Nunoo-Mensah, King's College Hospital & Cleveland Clinic London, London, UK

 

13:55 - 15:00 Lunch

 

15:00 - 16:35 More on the pelvic floor (ODS & OASIS) 

​

Moderators: Dudley Robinson, King's College Hospital, London, UK & Joaquim Costa-Pereira, Hospital de Braga, Braga, Portugal 

 

• Patient to avoid for obstructed defecation syndrome (ODS)/prolapse surgery - Liliana Bordeianou, Mass General Brigham HealthCare Colorectal Surgery Collaborative, Boston, USA

• Rectocele repair – From a colorectal and gynaecological perspective - Giulio Santoro Treviso Regional Hospital, Treviso, Italy.

• Does a missed obstetric anal sphincter injury at time of delivery affect short-term functional outcome - Gregory Thomas, St Mark’s Hospital, London, UK

• Appropriate surgical repair of 3rd and 4th degree perineal lacerations and post-operative management - Alex Digesu, St Mary's Hospital, London

• New perspectives for a reliable early detection and repair to improve outcome OASIS - Annika Taithongchai. King's College Hospital, London, UK

• Discussion

​​

16:35 - 17:05 Coffee Break

​

17:05 - 18:25 Functional Problems after Cancer Treatment

 

Moderators:  Philip Bearn, Ashford and St Peter's Hospitals, Chertsey, UK​​ & Rakesh Bhardwaj, Dartford and Gravesham NHS Trust, Dartford, UK

​

• Functional consequences of colon cancer treatment - Narimantas Samalavicius, Republican Vilnius University Hospital, Vilnius, Lithuania 

• Low Anterior Resection Syndrome - Incidence, severity and pathophysiology - Tomas Poskus, Vilnius University Hospital, Vilnius, Lithuania 

• Low Anterior Resection Syndrome - Treatment options which work and those that don’t work? - Gregory Thomas, St Mark’s Hospital, London, UK

• Sexual & urinary dysfunction following rectal cancer treatment - is there hope for our patients? - Jean-Jacques Tuech, CHU-Hôpitaux de Rouen, Rouen, France

• Discussion

 

18:25  Close

​

8 CPD POINTS AWARDED BY THE ASSOCIATION OF SURGEONS OF GREAT BRITAIN AND IRELAND (ASGBI) FOR ATTENDANCE ON 9TH JANUARY 2025

​

Friday 10th January 2025 - Colorectal Cancer

 

08:20 - 08:30 Welcome

 

08:30 - 08:40 Colorectal cancer 'The Big Picture' - Joseph Nunoo-Mensah, King's College Hospital & Cleveland Clinic London, London, UK

​

08:40 - 10:15 Colon Cancer Session:

​​​

Moderators: Piero Nastro, Dartford and Gravesham NHS Trust, Dartford, UK & Narimantas Samalavicius, Republican Vilnius University Hospital, Vilnius, Lithuania.

​

• Modernization of the TNM Staging System: Prioritizing EMVI and tumour deposits Over lymph node status - Gina Brown, Imperial College London and Imperial College Healthcare Trust, London, UK

• Is Routine CME necessary for right sided colon cancer - Danilo Miskovic, St Mark’s Hospital, London, UK

• Neo-adjuvant treatment for locally advanced colon cancer: what should we do based on current evidence - Paul Ross, Guy's & St Thomas' NHS Foundation, London, UK

• Potentially curable stage IV colon cancer. Upfront surgery or neoadjuvant therapy? When or where?- Elaine Burns, St Marks Hospital, London, UK

• Discussion

 

10:15 - 10:45 Coffee Break

 

10:45 - 12:15 Emerging Therapies & Strategies in Colorectal Cancer Management

​

Moderators: - Paul Ross, Guy's & St Thomas' NHS Foundation, London, UK & Mark Harrison, Mount Vernon Hospital, London, UK

​

• Immunotherapy in colorectal cancer - Kai-Keen Shiu, University College Hospital, London, UK

• Molecular profiling and personalized treatment - Nirupa Murugaesu, Guy's & St Thomas' NHS Foundation, London, UK

• Deep learning modelling and molecular predictors of response to neoadjuvant chemoradiotherapy (nCRT) - Kasia Owczarczyk, Guy's & St Thomas' NHS Foundation, London, UK

• The clinical use of liquid biopsies and early detection technologies in the postoperative management of colorectal cancer - Naureen Starling, Royal Marsden Hospital NHS, London, UK

• Discussion

​

12:15 - 12:45 DEBATE I:

​​

Total Neoadjuvant Treatment (TNT) in Rectal Cancer: Over or Under-utilised? Robert Glynne-Jones, Mount Vernon Hospital, London, UK (for overuse) vs. Mark Harrison (For underutilised) Mount Vernon Hospital, London, UK

​

Moderators: - Philippe Rouanet, Montpellier Cancer Institute, Montpellier, France & Asad Qureshi, Guy's & St Thomas' NHS Foundation, London, UK

​

12:45 - 13:15  DEBATE II:

​​

T2N0 Rectal cancer. Standard total mesorectal excision (TME) vs. Non-standard approach with NACRT & WW to achieve organ preservation. Brendan Moran, Basingstoke & Hampshire Hospital Foundation. Basingstoke, UK (For TME) vrs Jérémie Lefevre, Saint-Antoine Hospital, Paris, France (for NACRT & WW)] 

​

Moderators: - Robert Glynne-Jones, Mount Vernon Hospital, London, UK & Rodrigo Perez, Sao Paolo, Brazil

​

13:15 - 14:15 Lunch

 

14:15 - 15:45 Rectal Cancer Session

 

Moderators: Ian Jenkins, St Marks Hospital, London & Gordon Buchanan, Lister Hospital, London, UK 

​

• Challenges in defining and addressing staging and restaging of rectal cancer - Gina Brown, Imperial College London and Imperial College Healthcare Trust, London, UK

• How to implement an organ preservation strategy? Julio Garcia-Aguilar, Memorial Sloan Kettering Cancer Center, New York, USA

• From TaTME to Watch & Wait: Does Norway's move to ban raise red flags! - Hans Wasmuth, St Olav's Hospital, Trondheim University Hospital, Trondheim, Norway.

• Two years on at DDCRS! Am I still worried about The Achilles heel of Watch and Wait? Rodrigo Perez, Sao Paolo, Brazil

• Discussion

​​

15:45 - 16:05 The Fillor (Phi) Caushaj Oration

 

Moderators: Narimantas Samalavicius, Republican Vilnius University Hospital, Vilnius, Lithuania 

​

​Sphincter Preservation in Rectal Cancer: Is Robotic Surgery the 'New Gold Standard', or does TaTME prevail - Philippe Rouanet, Montpellier Cancer Institute, Montpellier, France​

​

16:05- 16:35 Coffee

​

16:35 - 17:05 DEBATE III:

​

Does Neo-adjuvant chemoradiotherapy increase sphincter preservation. Paris Tekkis (For Yes) Royal Marsden Hospital NHS, London, UK vrs - Jean-Jacques Tuech, CHU-Hôpitaux de Rouen, Rouen, France (For No)

​

Moderators: George Reese, Charing Cross Hospital & Cleveland Clinic London, London, UK & Arne E Faerden, Akershus University Hospital, Lørenskog, Norway.

​

17:05 - 18:35 Stage IV Peritoneal Colorectal cancer

​

Moderators: Brendan Moran, Basingstoke & Hampshire Hospital Foundation, Basingstoke, UK & Paris Tekkis (For Yes) Royal Marsden Hospital NHS, London, UK 

​​​

• Diagnosis and staging of peritoneal colorectal cancer - Michelle Dinsey, Basingstoke & Hampshire Hospital Foundation, Basingstoke, UK

• Prognostic factors in peritoneal colorectal cancer & current approaches to systemic therapy - Khurum Khan, University College Hospital, London, UK

• Current controversies of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) - Nirooshun Rajendran, Barking, Havering and Redbridge University Hospitals NHS Trust, Romford, Essex,

• Emerging, treatments, research and clinical trials in peritoneal colorectal cancer - Jamie Murphy, Cleveland Clinic London, London, UK

• Discussion

​​

18:35 Closing Remarks

​

8 CPD POINTS AWARDED BY THE ASSOCIATION OF SURGEONS OF GREAT BRITAIN AND IRELAND (ASGBI) FOR ATTENDANCE ON 10TH JANUARY 2025

​​​​​​